What does the ICER framework assess in the context of genetic testing?

The ICER framework, which stands for the Institute for Clinical and Economic Review, is designed to assess the value of healthcare interventions, including genetic testing. In the context of genetic testing, the ICER framework evaluates how effective a genetic intervention is relative to its cost, helping to determine its overall value to patients and the healthcare system.

By considering both the clinical effectiveness and the economic impact of genetic testing, the ICER framework provides important insights that can guide healthcare providers, policymakers, and patients in making informed decisions about which genetic tests to use and under what circumstances. This assessment involves looking at how genetic interventions can improve health outcomes, reduce the risk of diseases, or lead to more efficient healthcare spending.

While the other choices offer relevant aspects related to genetic testing, they do not fully encapsulate the primary purpose of the ICER framework. For instance, cost of procedure modifications might relate to specific adjustments in testing methods but does not address value in a broader context. Ethical implications are crucial in genetic interventions but fall outside the ICER's primary focus on cost-effectiveness. Long-term health outcomes are certainly part of the evaluation, but they are assessed within the framework of overall value rather than as standalone criteria.